Bolsa PT - Gráfico 3 Meses e Resumo de Sepracor Inc. [SEPR]

Sepracor Inc. - [Ticker: SEPR]
Última Trade	0,000	Range 52 Semanas	[0,000 - 0,000]
Hora da Última Trade	- 00:00:00	Price-Target 1 Ano	0,000
Variação	N/A (N/A)	Capitalização Bolsista	0
Bid / Ask	N/A	EPS	0,00
Abertura	0,000	PER	0,00%
Máximo	0,000	Pagamento Dividendo
Mínimo	0,000	Data Ex-Dividendo
Fecho Anterior	0,000	Yield
Volume	0	Volume Médio (3m)	0
Nota: Os dados podem apresentar atraso de alguns minutos.

Ver cotações de outros activos

Intraday 5 dias 1 mes 3 meses 6 meses 1 ano 2 anos 5 anos 10 anos Use este gráfico no seu website!
Gráfico de Sepracor Inc. - [Ticker: SEPR]

Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:

Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

Notícias sobre Sepracor Inc. [SEPR]: (ordenadas por relevância)

greenenergy24.com

Global Loratadine Market 2018 Exclusive Manufacturers- Sandoz, Mylan and Sepracor
greenenergy24.com
A latest detailed analysis on Global Loratadine Market report studies the new opportunity appraisal of Loratadine market (2018 ? 2023). According to the Loratadine business intelligence analysis, the global Loratadine market is likely to rise to X.X ...

e mais »

Tactical Business

Global Asthma Medication Market Demand 2018- AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc ...
Tactical Business
Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The report also takes into account the latest enhancements while foretelling the expansion of the key players.

Paris Ledger

Global Desloratadine Industry 2018 ? Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor ...
Paris Ledger
... Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan Poly Pharm ...

Global Loratadine Market 2018 Outline- Mylan, Sepracor, Sandoz
faircolumnist.com
This latest research report that completely centers Global Loratadine Market is an intensive analysis of propulsive forces, propulsive risks, business opportunities, Loratadine threats and challenges includes in Loratadine market. It provides ...

e mais »

364Analyze.com (press release)

Market Research on Allergy Treatment Market 2016 and Analysis to 2026
364Analyze.com (press release)
... market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and ...

e mais »

BSA bureau (press release)

Sumitomo Dainippon appoints Nomura as President & CEO
BSA bureau (press release)
In 2010, Sunovion (formerly Sepracor Inc.), was acquired by Sumitomo Dainippon. Nomura took the position of the Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc. in 2012. Following 2014, he became associated with the ...

e mais »

Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer
GlobeNewswire (press release)
Mr. Hastings also previously served as Vice President, Chief Financial Officer and Treasurer of ArQule Inc. During his tenure at ArQule, he played an important role in ArQule's transition into a drug discovery and development organization, and in two ...

Business Wire (press release)

Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
Business Wire (press release)
Prior to Auxilium, he was Vice President, General Counsel and Corporate Secretary of Enobia Pharma, Inc. Prior to that, Mr. Trachtenberg served as Vice President and Associate General Counsel of Sepracor Inc. (now known as Sunovion Pharmaceuticals ...

e mais »

Business Wire (press release)

Rodin Therapeutics Expands Leadership Team, Adding Extensive Experience in Clinical and Business Development
Business Wire (press release)
She then joined Sunovion Pharmaceuticals, Inc. (formerly Sepracor), moving through positions of increasing responsibility into the role of vice president for corporate development and licensing. Sullivan played an instrumental role in the company's ...

Business Wire (press release)

BioClin Therapeutics Appoints Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, MD, as ...
Business Wire (press release)
Dr. Currie has over 25 years of drug development experience in both pharmaceutical and biotechnology companies, having held senior leadership roles at Dynavax Technologies Corp., Regeneron Pharmaceuticals, Sepracor Inc. and PDL Biopharma.

e mais »

Desloratadine Market Outlook 2018 Global: Top Companies, Trends And Progress Factors Specifics For Business ...
Newszak (blog)
Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...

e mais »

Business Wire (press release)

Entasis Therapeutics Appoints David C. Hastings to Board of Directors
Business Wire (press release)
BUSINESS WIRE)--Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the appointment of David C. Hastings to the company's Board of ...

e mais »

Bellicum Pharmaceuticals Appoints Edmund P. Harrigan, MD to its Board of Directors
GlobeNewswire (press release)
In addition to his experience at Pfizer, Dr. Harrigan previously served as President & CEO of Karuna Pharmaceuticals, and in senior clinical leadership positions at Neurogen Corp. and Sepracor, Inc. Prior to entering the pharmaceutical industry in 1990 ...

e mais »

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
Business Wire (press release)
Prior to joining Dyax, Todd was at Sunovion Pharmaceuticals, Inc. (previously Sepracor Inc., prior to its acquisition by Sumitomo Dainippon Pharma Co., Ltd), where he served in several roles of increasing responsibility including Vice President ...

e mais »

Business Wire (press release)

Kala Pharmaceuticals Strengthens Commercial Organization in Preparation for First Product Launch
Business Wire (press release)
BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, today announced the ...

Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.